Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.760
-0.120 (-4.17%)
At close: Mar 27, 2026, 4:00 PM EDT
2.705
-0.055 (-2.00%)
After-hours: Mar 27, 2026, 7:42 PM EDT
Fortress Biotech Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fortress Biotech stock has a target of 17, which predicts a 515.94% increase from the current stock price of 2.76.
Price Target: $17 (+515.94%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 23, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Fortress Biotech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +515.94% | Feb 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $17 | Strong Buy | Maintains | $26 → $17 | +515.94% | Aug 21, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 → $16 | Strong Buy | Reiterates | $15 → $16 | +479.71% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +842.03% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +769.57% | Jul 19, 2024 |
Financial Forecast
Revenue This Year
74.81M
from 57.68M
Increased by 29.71%
Revenue Next Year
111.72M
from 74.81M
Increased by 49.34%
EPS This Year
0.32
from -2.69
EPS Next Year
0.01
from 0.32
Decreased by -96.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 84.7M | 116.3M | |
| Avg | 74.8M | 111.7M | |
| Low | 64.7M | 106.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 46.9% | 55.5% | |
| Avg | 29.7% | 49.3% | |
| Low | 12.1% | 41.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.75 | 0.65 | |
| Avg | 0.32 | 0.01 | |
| Low | -0.08 | -0.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 102.6% | |
| Avg | - | -96.8% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.